Skip to content
DraconiticResearch
Search Sources API
210,418 studies31 sourcesUpdated 30 min ago

Oncology

5,311 studies490 in 7 days2,547 in 30 days

Filters
Type
Date
Clear

Latest

5,311 studies

  1. Interactions of Salicyluric Acid with Metal Ions and Ascorbic Acid: Possible Biological and Toxicity Implications in Aspirin Use.
    Viktor A Timoshnikov, Aleksandr A Deriskiba, Vladimir E Koshman +2
    BiologyPeer-reviewedCC BYFull textOncologyEurope PMC
  2. Prognostic value of systemic inflammatory markers in patients with malignancy-associated pulmonary thromboembolism: A retrospective observational study.
    Esra Arslan Aksu, Levent Özdemir, Savaş Gegin +1
    MedicinePeer-reviewedCC BY-NCFull textOncologyEurope PMC
  3. Clinicopathological Features of DLL3 Expression and T-Cell Infiltration in LCNEC: Insights From Pathology and Clinical Response to Tarlatamab.
    Shotaro Kaneko, Naoki Furuya, Yoshihisa Sugiura +8
    Thoracic cancerPeer-reviewedCC BYFull textOncologyEurope PMC
  4. Epigenetic Priming with Oral Decitabine/Cedazuridine Combined with Nivolumab in Unresectable or Metastatic Mucosal Melanoma: Clinical and Correlative Findings from a Phase Ib/II Trial.
    Jessica S W Borgers, Cheng-Chang Wu, Theresa M Medina +11
    CancersPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  5. Integrating ctDNA-based ESR1m monitoring into first-line care for ER+, HER2- advanced breast cancer: a consensus workflow.
    Yara Abdou, Amber Cipriani, Trevor Feinstein +4
    The oncologistPeer-reviewedCC BYFull textOncologyEurope PMC
  6. Systemic immune-inflammation index and in-hospital mortality in critically ill patients with acute asthma exacerbation: A retrospective cohort study.
    Phan Ngoc An Huynh, Vu Thanh Le, Ngoc Thu Le +6
    MedicinePeer-reviewedCC BY-NCFull textOncologyEurope PMC
  7. Trends and projections of colorectal carcinoma mortality in U.S. adults, 1999-2050: A CDC WONDER-based ecological time-series analysis.
    Kanza Atif, Eshal Atif, Vishan Das +8
    MedicinePeer-reviewedCC BYFull textOncologyEurope PMC
  8. Research trends and hotspots in colorectal cancer screening: Bibliometric and visualization analysis (2015-2024).
    Jinkai Zhou, He Zhou, Jiayu Xu +3
    MedicinePeer-reviewedCC BYFull textOncologyEurope PMC
  9. Ageing and Out-of-Region Cancer Care in South Korea: Determinants and Age-Group Treatment Effects
    CN Kim, Y Choi, SJ Yoon
    The European Journal of Public HealthPeer-reviewedCC BY-NC 4.0Full textOncologyPMCEurope PMC
  10. Impact of the COVID-19 Pandemic on cancer incidence: A Joinpoint Analysis from Kenitra, Morocco
    R Elgui, S Ed-day, A Haddan +2
    The European Journal of Public HealthPeer-reviewedCC BY-NC 4.0Full textOncologyPMCEurope PMC
  11. Evaluation of Slovenian National Cancer Control Programme – Guiding the Way Forward
    A Dvornik, S Tomšič, A Duratović Konjević +2
    The European Journal of Public HealthPeer-reviewedCC BY-NC 4.0Full textOncologyPMCEurope PMC
  12. Mammographic screening effectiveness in reducing breast cancer mortality in Sicily, Italy, 2008–2023
    M La Bella, S Scondotto, W Pollina Addario +4
    The European Journal of Public HealthPeer-reviewedCC BY-NC 4.0Full textOncologyPMCEurope PMC
  13. Polygenic Risk Score-Stratified Cancer Screening: Building the Evidence Base
    E Pascucci, N Lentini, A Valz Gris +5
    The European Journal of Public HealthPeer-reviewedCC BY-NC 4.0Full textOncologyPMCEurope PMC
  14. Uptake of colorectal cancer screening in Hungary: results from a cross-sectional study
    A Gyulai, E Kiss-Tóth, A Masa +2
    The European Journal of Public HealthPeer-reviewedCC BY-NC 4.0Full textOncologyPMCEurope PMC
  15. Colorectal cancer screening in Filipino-born Australians: knowledge, attitudes and practices
    A M Silvano
    The European Journal of Public HealthPeer-reviewedCC BY-NC 4.0Full textOncologyPMCEurope PMC
  16. A Dual-Marker DNA Methylation Assay Enables High-Sensitivity Detection of Malignant Effusions Across Cancer Types.
    Ting Wang, Ting Liang, Matthew Kafarski +18
    CancersPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  17. Implementation of Risk Prediction Models Using Electronic Health Data for Early Detection of Pancreatic Cancer: A Prospective Pilot Feasibility Study.
    Bechien U Wu, Tiffany Q Luong, Eva Lustigova +5
    Cancer medicinePeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  18. Basal Marker ΔNp63α Is Enriched in Pancreatic Cancer Metastases but Not in Primary Tumors Post-Chemotherapy.
    Daniel H Ryan, Yuuki Ohara, Michael J Kruhlak +4
    Cancer medicinePeer-reviewedCC BY-NCFull textOncologyEurope PMC
  19. Preoperative Systemic Inflammatory Indices as Adjunctive Biomarkers for Malignancy Prediction in Bethesda III (AUS) Thyroid Nodules.
    Gökhan Rıza Baykal, Müge Keskin, Kübra Katipoğlu +5
    CancersPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  20. Impact of the COVID-19 pandemic on diagnosis, treatment, and prognosis of cervical, endometrial, and ovarian cancers: A retrospective cohort study based on the SEER database.
    Chunyan Tan, Huibo Dai, Xingya Liu +3
    MedicinePeer-reviewedCC BYFull textOncologyEurope PMC
  21. Burden of CNS neoplasms in the Middle East and North Africa from 1990 to 2023, with projections to 2050: Insights from Global Burden of Disease.
    Ibraheem Altamimi, Alaa Alanazi, Abdullah Abdulaziz Alnaim +9
    MedicinePeer-reviewedCC BYFull textOncologyEurope PMC
  22. Efficacy and Safety of Immune Checkpoint Inhibitors for Lung Cancer Complicated by Interstitial Pneumonia: The CS-Lung 003 Study, Branch Number 28.
    Kosuke Hamai, Nobuhiro Kanaji, Naoki Watanabe +12
    Thoracic cancerPeer-reviewedCC BYFull textOncologyEurope PMC
  23. Influenza A (H1N1) virus infection complicated by checkpoint inhibitor pneumonitis: A case report.
    Yifan Cheng, Huiying Zhao, Youzhong An
    MedicinePeer-reviewedCC BYFull textOncologyEurope PMC
  24. Completed clinical trials of p53-targeted therapeutic strategies in cancer: A cross-sectional ClinicalTrials.gov registry analysis.
    Nasser M Alorfi, Nouf M Alourfi
    MedicinePeer-reviewedCC BYFull textOncologyEurope PMC
  25. Mapping the symptom management journey across the treatment cycle for breast cancer patients: A qualitative study.
    WenQian Shao, JingPing Qian, WeiMin Xu +1
    MedicinePeer-reviewedCC BY-NCFull textOncologyEurope PMC